Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

PolyPeptide Group AG

PPGN
Current price
28.8 CHF -1.7 CHF (-5.57%)
Last closed 30.4 CHF
ISIN CH1110760852
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange SIX Swiss Exchange
Capitalization 1 027 604 421 CHF
Yield for 12 month +42.86 %
1Y
3Y
5Y
10Y
15Y
PPGN
21.11.2021 - 28.11.2021

PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorders, neurology, ophthalmology, cardiovascular, and gastrointestinal applications. It also provides peptides for cosmetics; and individualized peptide therapeutics. The company was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V. Address: Neuhofstrasse 24, Baar, Switzerland, 6340

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

28.33 CHF

P/E ratio

Dividend Yield

Current Year

+303 187 770 CHF

Last Year

+265 906 800 CHF

Current Quarter

+178 425 130 CHF

Last Quarter

+124 762 640 CHF

Current Year

+4 393 011 CHF

Last Year

+49 202 288 CHF

Current Quarter

+7 045 662 CHF

Last Quarter

-2 528 679 CHF

Key Figures PPGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 450 689 CHF
Operating Margin TTM -9.31 %
PE Ratio
Return On Assets TTM -2.34 %
PEG Ratio
Return On Equity TTM -7.68 %
Wall Street Target Price 28.33 CHF
Revenue TTM 326 251 444 CHF
Book Value 11 CHF
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2.4 %
Dividend Yield
Gross Profit TTM 52 420 072 CHF
Earnings per share -0.83 CHF
Diluted Eps TTM -0.83 CHF
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY -60.8 %
Profit Margin -8.83 %

Dividend Analytics PPGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

123 %

Dividend History PPGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 28.04.2022
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date 02.05.2022

Stock Valuation PPGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 217.3913
Enterprise Value Revenue 3.5245
Price Sales TTM 3.1497
Enterprise Value EBITDA 127.0289
Price Book MRQ 3.013

Financials PPGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PPGN

For 52 weeks

14.23 CHF 36.1 CHF
50 Day MA 30.67 CHF
Shares Short Prior Month
200 Day MA 28.41 CHF
Short Ratio
Shares Short
Short Percent